Ionis Pharmaceuticals, Inc. (LON:0JDI)
London · Delayed Price · Currency is GBP · Price in USD 73.14
+0.64 (0.88%)
At close: Oct 17, 2025
Ionis Pharmaceuticals Market Cap
Ionis Pharmaceuticals has a market cap or net worth of 8.70 billion as of October 17, 2025. Its market cap has increased by 85.99% in one year.
Market Cap
8.70B
Enterprise Value
8.47B
Revenue
689.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
73.14
Market Cap Chart
Since May 17, 1991, Ionis Pharmaceuticals's market cap has increased from 61.76M to 8.70B, an increase of 13,984.02%. That is a compound annual growth rate of 15.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 8.70B | 97.26% |
| Dec 31, 2024 | 4.41B | -22.62% |
| Dec 29, 2023 | 5.70B | 27.97% |
| Dec 30, 2022 | 4.45B | 40.32% |
| Dec 31, 2021 | 3.17B | -45.19% |
| Dec 31, 2020 | 5.79B | -9.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.74B |
| GSK plc | 65.34B |
| Haleon | 31.33B |
| Smith & Nephew | 11.41B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 3.93B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.82B |